JP2008536825A5 - - Google Patents

Download PDF

Info

Publication number
JP2008536825A5
JP2008536825A5 JP2008504368A JP2008504368A JP2008536825A5 JP 2008536825 A5 JP2008536825 A5 JP 2008536825A5 JP 2008504368 A JP2008504368 A JP 2008504368A JP 2008504368 A JP2008504368 A JP 2008504368A JP 2008536825 A5 JP2008536825 A5 JP 2008536825A5
Authority
JP
Japan
Prior art keywords
phenyl
alkyl
piperidin
ethyl
ethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008504368A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008536825A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/011663 external-priority patent/WO2006105304A2/en
Publication of JP2008536825A publication Critical patent/JP2008536825A/ja
Publication of JP2008536825A5 publication Critical patent/JP2008536825A5/ja
Withdrawn legal-status Critical Current

Links

JP2008504368A 2005-03-31 2006-03-30 フェニルおよびピリジルlta4hモジュレータ Withdrawn JP2008536825A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66719905P 2005-03-31 2005-03-31
PCT/US2006/011663 WO2006105304A2 (en) 2005-03-31 2006-03-30 Phenyl and pyridyl lta4h modulators

Publications (2)

Publication Number Publication Date
JP2008536825A JP2008536825A (ja) 2008-09-11
JP2008536825A5 true JP2008536825A5 (cg-RX-API-DMAC10.html) 2009-05-14

Family

ID=36950133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008504368A Withdrawn JP2008536825A (ja) 2005-03-31 2006-03-30 フェニルおよびピリジルlta4hモジュレータ

Country Status (17)

Country Link
US (1) US20060223792A1 (cg-RX-API-DMAC10.html)
EP (1) EP1868605A2 (cg-RX-API-DMAC10.html)
JP (1) JP2008536825A (cg-RX-API-DMAC10.html)
KR (1) KR20080003385A (cg-RX-API-DMAC10.html)
CN (1) CN101189012A (cg-RX-API-DMAC10.html)
AU (1) AU2006230379A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0607742A2 (cg-RX-API-DMAC10.html)
CA (1) CA2603122A1 (cg-RX-API-DMAC10.html)
CO (1) CO6382173A2 (cg-RX-API-DMAC10.html)
CR (1) CR9480A (cg-RX-API-DMAC10.html)
EA (1) EA200702128A1 (cg-RX-API-DMAC10.html)
IL (1) IL186432A0 (cg-RX-API-DMAC10.html)
MX (1) MX2007012235A (cg-RX-API-DMAC10.html)
NI (1) NI200700250A (cg-RX-API-DMAC10.html)
NO (1) NO20075429L (cg-RX-API-DMAC10.html)
WO (1) WO2006105304A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200709346B (cg-RX-API-DMAC10.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1976828T3 (en) 2005-12-29 2017-03-06 Celtaxsys Inc DIAMINE DERIVATIVES AS INhibitors of Leukotriene A4 HYDROLASE
JP2009269819A (ja) * 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物
BRPI0911336A2 (pt) * 2008-04-11 2021-06-29 Janssen Pharmaceutica N.V. tiazolopiridin-2-iloxifenil e tiazolopirazin-2-iloxifenil aminas como moduladores de leucotrieno a4 hidrolase
NZ596137A (en) * 2009-05-14 2013-08-30 Janssen Pharmaceutica Nv Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
WO2012125598A1 (en) 2011-03-14 2012-09-20 Boehringer Ingelheim International Gmbh Benzodioxane inhibitors of leukotriene production
US9139567B2 (en) 2011-07-19 2015-09-22 Boehringer Ingelheim International Gmbh Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase
FR2984730A1 (fr) * 2011-12-22 2013-06-28 Diverchim Nouvelles compositions cosmetiques anti-age et depigmentantes
US8946203B2 (en) 2012-03-06 2015-02-03 Boehringer Ingelheim International Gmbh Benzodioxane inhibitors of leukotriene production
NZ628587A (en) 2012-03-06 2016-07-29 Boehringer Ingelheim Int Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2014014874A1 (en) 2012-07-17 2014-01-23 Boehringer Ingelheim International Gmbh Pyrazole derivatives which inhibit leukotriene production
JP6527851B2 (ja) 2013-03-12 2019-06-05 セルタクシス,インコーポレイテッド ロイコトリエンa4加水分解酵素を阻害する方法
KR20150127245A (ko) 2013-03-14 2015-11-16 켈탁시스, 인코퍼레이티드 류코트라이엔 a4 가수분해효소의 저해제
EP2968265A4 (en) * 2013-03-14 2016-12-28 Celtaxsys Inc INHIBITORS OF THE LEUKOTRIEN A4 HYDROLASE
AU2014239567B2 (en) 2013-03-14 2017-12-14 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
US9303018B2 (en) 2013-07-15 2016-04-05 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
JP2016523982A (ja) 2013-07-15 2016-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成の阻害剤
BR102013020313B1 (pt) * 2013-08-09 2021-07-06 Fundação Oswaldo Cruz derivados bifeniloxi-alquil-aminas e ariloxi-alquil-aminas, e, composição farmacêutica
US9624199B2 (en) 2013-12-19 2017-04-18 Bayer Pharma Aktiengesellschaft Substituted bipiperidinyl derivatives
WO2015091415A1 (de) 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte bipiperidinyl-derivate als adrenorezeptor alpha 2c antagonisten
JOP20200052A1 (ar) 2013-12-19 2017-06-16 Bayer Pharma AG بيبريدينيل تتراهيدرو كوينولينات مستبدلة واستخدامها كمعضدات مستقبل أدريني ألفا- 2c
EA201691278A1 (ru) 2013-12-19 2017-02-28 Байер Фарма Акциенгезельшафт Замещенные пиперидинил-тетрагидрохинолины
KR101499007B1 (ko) * 2014-04-24 2015-03-05 고려대학교 산학협력단 염증성 질환의 예방 또는 치료용 약학 조성물
EP3215489B1 (en) 2014-11-03 2019-07-24 OLON S.p.A. Method for the preparation of 1-(2-halogen-ethyl)-4 piperidine-carboxylic acid ethyl esters
PT109740B (pt) * 2016-11-14 2020-07-30 Hovione Farmaciencia Sa Processo para a preparação de brometo de umeclidínio
US11827616B2 (en) 2017-05-04 2023-11-28 Discovery Purchaser Corporation Heterocyclic compounds as pesticides
JP7386815B2 (ja) 2018-05-31 2023-11-27 セルタクシー、エルエルシー 呼吸器疾患患者の肺増悪を軽減する方法
US11993582B2 (en) * 2018-07-31 2024-05-28 Novartis Ag Crystalline forms of a LTA4H inhibitor
CN113784713A (zh) * 2019-01-11 2021-12-10 纳吉斯制药股份有限公司 白三烯合成抑制剂
CN110229091B (zh) * 2019-06-21 2022-11-22 天津科技大学 具有白三烯a4水解酶抑制作用的1,5-二取代吲哚衍生物及应用
CN113683491A (zh) * 2021-09-01 2021-11-23 王传良 一种4-(2-溴乙基)苯酚的制备方法
EP4426284A4 (en) 2021-11-01 2025-11-12 Alkahest Inc Benzodioxane Leukotriene A4 Hydrolase (LTA4H) Modulators for the Prevention and Treatment of Age-Related Diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038412A (en) * 1975-08-25 1977-07-26 Richardson-Merrell Inc. N-(phenylether-substituted benzyl)alkanediamines
JPH0696532B2 (ja) * 1988-08-11 1994-11-30 山之内製薬株式会社 血小板活性化因子拮抗剤
CA2117250C (en) * 1991-10-04 1999-03-02 Atsuro Nakazato Alkoxyphenylalkylamine derivatives
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US6506876B1 (en) * 1994-10-11 2003-01-14 G.D. Searle & Co. LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5925654A (en) * 1997-03-12 1999-07-20 G.D. Searle & Co. LTA4 , hydrolase inhibitors
US6110944A (en) * 1997-03-12 2000-08-29 G. D. Searle & Co. LTA4, hydrolase inhibitors
JPWO2002044130A1 (ja) * 2000-11-29 2004-04-02 杏林製薬株式会社 置換カルボン酸誘導体
DE602004016002D1 (de) * 2003-07-28 2008-10-02 Janssen Pharmaceutica Nv Benzimidazol-, benzothiazol- und benzoxazolderivate und deren verwendung als lta4h-modulatoren
CN101407471A (zh) * 2003-08-29 2009-04-15 小野药品工业株式会社 能够结合s1p受体的化合物及其药物用途
ES2527117T3 (es) * 2003-08-29 2015-01-20 Ono Pharmaceutical Co., Ltd. Compuesto capaz de unirse a receptor SIP y uso farmacéutico del mismo

Similar Documents

Publication Publication Date Title
JP2008536825A5 (cg-RX-API-DMAC10.html)
TWI359140B (cg-RX-API-DMAC10.html)
AU2003213361B2 (en) Nitrogenous heterocyclic compound and medicine thereof
US7196080B2 (en) Phenylpyridinecarbonylpiperazinederivative
EP2314586B1 (en) 2-Acylaminothiazole derivative or salt thereof
ME02532B (me) Jedinjenja beta-laktama supstituisana amidinom, njihovo dobijanje i upotreba kao antibakterijskih sredstava
JP2006500348A5 (cg-RX-API-DMAC10.html)
JP2012508274A5 (cg-RX-API-DMAC10.html)
JP2006509715A5 (cg-RX-API-DMAC10.html)
CA3172387A1 (en) Indazole based compounds and associated methods of use
JPWO2020038415A5 (cg-RX-API-DMAC10.html)
JP2018519323A5 (cg-RX-API-DMAC10.html)
RU2005131833A (ru) Азотсодержащие гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
NZ601794A (en) Di - substituted pyridine derivatives as anticancers
JP2010514788A5 (cg-RX-API-DMAC10.html)
JP2010520893A5 (cg-RX-API-DMAC10.html)
HRP20120738T1 (hr) Inhibitori kinaza akt i p70 s6
JP2006506380A5 (cg-RX-API-DMAC10.html)
CA2585053A1 (en) Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors
JP2020511452A5 (cg-RX-API-DMAC10.html)
JP2012530765A5 (cg-RX-API-DMAC10.html)
JP2010536821A5 (cg-RX-API-DMAC10.html)
JP2005529842A5 (cg-RX-API-DMAC10.html)
JP2014510695A5 (cg-RX-API-DMAC10.html)
JP2008517042A5 (cg-RX-API-DMAC10.html)